Clinical Trials on Adrenal Hyperplasia in Japan

Total 318 results

Sanofi

Completed

Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH

Benign Prostatic Hyperplasia

Japan
Astellas Pharma Inc

Completed

A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia

Benign Prostate Hyperplasia

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Comparative Study of KSO-0400 in BPH Patients With LUTS

Benign Prostatic Hyperplasia (BPH)

Japan
Sanofi

Completed

Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Japan
GlaxoSmithKline

Completed

Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects

Prostatic Hyperplasia

Japan
Sanofi

Completed

Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Japan
Eli Lilly and Company

Completed

Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension

Benign Prostatic Hyperplasia

Japan
Eli Lilly and Company

Completed

Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Taiwan, Japan
Diurnal Limited

Completed

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia (CONnECT)

Congenital Adrenal Hyperplasia

France, United States, Japan
Diurnal Limited

Enrolling by invitation

Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia

United States, France, Japan
Eli Lilly and Company
Nippon Shinyaku Co., Ltd.

Completed

A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

Benign Prostatic Hyperplasia

Japan
GlaxoSmithKline

Completed

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Prostatic Hyperplasia

Japan
Astellas Pharma Inc

Completed

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Overactive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Japan
Eli Lilly and Company

Completed

Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Korea, Republic of, Japan
Mie University

Completed

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Adrenal Tumors

Japan
GlaxoSmithKline

Completed

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Korea, Republic of, China, Japan, Taiwan
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Cushing's Syndrome | Ectopic Corticotropin Syndrome | Adrenal Adenoma | Adrenal Carcinoma | AIMAH | PPNAD

Japan
Dialysis Outcomes Heart Failure Aldactone Study...

Completed

Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients

End-stage Renal Failure

Japan
Toray Industries, Inc

Completed

A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment

Renal Impairment

Japan
Astellas Pharma Inc

Completed

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

Patients With Impaired Renal Function

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 in Patients With Primary Aldosteronism

Primary Aldosteronism

Japan
Eisai Co., Ltd.

Completed

Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.

End-Stage Renal Disease

Japan
Japan Blood Products Organization

Completed

The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.

End Stage Renal Disease

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment

Hypertension With Moderate Renal Impairment

Japan
Mitsubishi Tanabe Pharma America

Completed

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

Healthy | Renal Impairment

Japan
UCB Pharma
Parexel

Completed

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Healthy Subjects | Renal Impairments

Japan
Translational Research Center for Medical Innovation...
Niigata University

Completed

Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents (BRIGHTEN)

Chronic Kidney Disease | Renal Anemia

Japan
Novartis

Completed

SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction

Hypertension

Japan
Yokohama City University Medical Center

Completed

Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease

Diabetes Mellitus | Renal Failure | Essential Hypertension | Chronic Nephropathy

Japan
University of Shizuoka

Completed

The Effect of CoQ10 Administration on Hemodialysis Patients

Hemodialysis | Chronic Renal Failure

Japan
Astellas Pharma Inc

Completed

ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis

Patients With Impaired Renal Function and Haemodialysis

Japan
Iwata City Hospital
Hamamatsu University; University of Shizuoka

Completed

Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis Patients

Chronic Renal Failure

Japan
University of Shizuoka
Hamamatsu University; Maruyama Memorial General Hospital

Completed

Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients

Atherosclerosis | Hemodialysis | Chronic Renal Failure

Japan
Astellas Pharma Inc

Completed

ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis

Anemia | Hemodialysis | Renal Impairment

Japan
Novo Nordisk A/S
Sponsor: Corvidia Therapeutics Inc, a subsidiary of Novo Nordisk A/S

Completed

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. (RESCUE-2)

Inflammation | Chronic Kidney Disease | Cardiovascular Risk

Japan
Nara Medical University

Terminated

The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure

Heart Failure | Renal Failure

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Active, not recruiting

A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan

Advanced or Metastatic Renal Cell Carcinoma

Japan
Daiichi Sankyo, Inc.

Completed

A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment

Hypertension

Japan
Yamagata University

Unknown

Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma (CROSS-J-RCC)

Metastatic Renal Cell Carcinoma

Japan
Kumamoto University

Completed

Efficacy of Intravenous Iron Administration in Hemodialysis Patients

Hemodialysis | Iron Deficiency Anemia | Chronic Renal Failure | Renal Anemia

Japan
Kumamoto University

Terminated

Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study

Hypertension

Japan
Kumamoto University

Active, not recruiting

Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil

Coronary Artery Disease | End Stage Renal Disease

Japan
Takeda

Completed

Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"

Type 2 Diabetes Mellitus

Japan
University of Shizuoka

Unknown

Effect of Malnutrition on the Prognosis in Hemodialysis Patients

Malnutrition | Hemodialysis | Chronic Renal Failure

Japan
Nara Medical University

Unknown

Hemofiltration for Contrast-Induced Nephropathy

Chronic Kidney Disease | Cardiac Catheterization

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration

Chronic Renal Failure

Japan
Institute for Health Outcomes and Process Evaluation...

Completed

Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease (CAP-KD)

Kidney Failure, Chronic

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients With Chronic Kidney Disease

Chronic Kidney Disease

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment

Renal Impairment

Japan
Daiichi Sankyo Co., Ltd.

Completed

Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

Non-valvular Atrial Fibrillation

Japan

3

Subscribe